About Wockhardt Medicines Limited
Data last updated:
Wockhardt Medicines Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Wockhardt Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PLC322942.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Stephen Sabbas Dsouza and Sujatha Shashikant Shetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/501 5th Floor Kanakia Zillion Next To Kurla Bus Depot Kurla, Mumbai, Maharashtra, India – 400070.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wockhardt.com.
Company details
Contact details
Wockhardt Medicines Limited's registered office is in Mumbai, Maharashtra. Its website is wockhardt.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressA/501 5th Floor Kanakia Zillion Next To Kurla Bus Depot Kurla, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Wockhardt Medicines Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Wockhardt Medicines Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wockhardt Medicines Limited, buy the company report.
Board of directors of Wockhardt Medicines Limited
Wockhardt Medicines has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Stephen Sabbas Dsouza Also directs: Merind Limited, Sharanya Chemicals and Pharmaceuticals Private Limited, Banneret Trading Private Limited and 2 more | Director | 25 Mar 2019 | 7 Years 7 Months | Current |
| Sujatha Shashikant Shetty | Director | 30 Mar 2021 | 5 Years 7 Months | Current |
| Janet Gonsalves Also directs: Banneret Trading Private Limited, Wockhardt Holdings Limited | Director | 01 Jun 2022 | 4 Years 4 Months | Current |
Auditor
Wockhardt Medicines Limited is audited by B S R & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & CO LLP | FY 2023 | 101248W/W100022 |
Shareholding
The shareholding of Wockhardt Medicines Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wockhardt Medicines Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wockhardt Medicines Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wockhardt Medicines Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Wockhardt Medicines Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Wockhardt Medicines Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Janet Gonsalves ceased to be Additional Director on 30 Sep 2022.
News
Frequently asked questions
Wockhardt Medicines is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2019 (7+ years old) and is registered under CIN U74999MH2019PLC322942.
Wockhardt Medicines has 3 current directors:
- Stephen Sabbas Dsouza - Director
- Sujatha Shashikant Shetty - Director
- Janet Gonsalves - Director
The latest financial statements of Wockhardt Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Wockhardt Medicines is U74999MH2019PLC322942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wockhardt Medicines was incorporated on 25 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Janet Gonsalves ceased to be Additional Director on 30 Sep 2022. Janet Gonsalves was appointed as Director on 01 Jun 2022. Shivasubramanian A ceased to be Director on 31 May 2022. Wockhardt Medicines has 7 board changes on record in total.
Wockhardt Medicines can be reached through the website wockhardt.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Wockhardt Medicines is at A501 5th Floor Kanakia Zillion Next To Kurla Bus Depot Kurla, Mumbai, Maharashtra, India – 400070.
Wockhardt Medicines operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Wockhardt Medicines is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
